ArticleSpringerPlus2015

IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders.

Giorgio Calisti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.